Safety Assessment of Pluripotent Stem Cell Therapy Using Nanotechnology View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2014-2016

FUNDING AMOUNT

426075 USD

ABSTRACT

DESCRIPTION (provided by applicant): Human pluripotent stem cells are promising and potentially unlimited cell source for regenerative medicine; however, tumor formation is of major concern for cell therapy with pluripotent stem cells. Residual undifferentiated stem cells in preparations of stem cell derivatives, including cardiomyocyte differentiation cultures, have potential to proliferate and form teratoma upon transplantation, posing a major hurdle for safe cell therapy. Careful assessment of differentiation cultures and development of strategies to remove undifferentiated stem cells will facilitate qualification of final stem cell products for therapeutic use. In this study, we propose to develop sensitive, nanotechnology-based assays to detect residual undifferentiated cells, characterize cardiomyocyte differentiation cultures at various stages for their propensities to form teratomas, and evaluate strategies to selectively remove residual undifferentiated cells. Technology established in this study will be valuable for the development of novel cell therapy using human pluripotent stem cells. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8902262

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2210", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "426075"
    }, 
    "description": "DESCRIPTION (provided by applicant): Human pluripotent stem cells are promising and potentially unlimited cell source for regenerative medicine; however, tumor formation is of major concern for cell therapy with pluripotent stem cells. Residual undifferentiated stem cells in preparations of stem cell derivatives, including cardiomyocyte differentiation cultures, have potential to proliferate and form teratoma upon transplantation, posing a major hurdle for safe cell therapy. Careful assessment of differentiation cultures and development of strategies to remove undifferentiated stem cells will facilitate qualification of final stem cell products for therapeutic use. In this study, we propose to develop sensitive, nanotechnology-based assays to detect residual undifferentiated cells, characterize cardiomyocyte differentiation cultures at various stages for their propensities to form teratomas, and evaluate strategies to selectively remove residual undifferentiated cells. Technology established in this study will be valuable for the development of novel cell therapy using human pluripotent stem cells.", 
    "endDate": "2016-04-30T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.279885.9", 
      "type": "Organization"
    }, 
    "id": "sg:grant.3805221", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "3805221"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R21HL123928"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "nanotechnology", 
      "propensity", 
      "various stages", 
      "cardiomyocyte differentiation cultures", 
      "pluripotent stem cell therapies", 
      "preparation", 
      "teratoma", 
      "cell therapy", 
      "safe cell therapy", 
      "regenerative medicine", 
      "human pluripotent stem cells", 
      "novel cell therapies", 
      "strategies", 
      "description", 
      "pluripotent stem cells", 
      "potential", 
      "applicants", 
      "residual undifferentiated cells", 
      "stem cell derivatives", 
      "study", 
      "assay", 
      "development", 
      "major hurdle", 
      "undifferentiated stem cells", 
      "therapeutic use", 
      "safety assessment", 
      "tumor formation", 
      "unlimited cell source", 
      "differentiation culture", 
      "careful assessment", 
      "technology", 
      "qualification", 
      "major concern", 
      "final stem cell products", 
      "transplantation"
    ], 
    "name": "Safety Assessment of Pluripotent Stem Cell Therapy Using Nanotechnology", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.189967.8", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.189967.8", 
          "name": "EMORY UNIVERSITY", 
          "type": "Organization"
        }, 
        "familyName": "XU", 
        "givenName": "CHUNHUI", 
        "id": "sg:person.01207330163.59", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01207330163.59", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.3805221"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T12:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_15.xml.gz", 
    "startDate": "2014-08-15T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8902262"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.3805221'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.3805221'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.3805221'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.3805221'


 

This table displays all metadata directly associated to this object as RDF triples.

79 TRIPLES      19 PREDICATES      57 URIs      49 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.3805221 schema:about anzsrc-for:2210
2 schema:amount N2ae753aae5064c6fad29b0bde0e7d8c7
3 schema:description DESCRIPTION (provided by applicant): Human pluripotent stem cells are promising and potentially unlimited cell source for regenerative medicine; however, tumor formation is of major concern for cell therapy with pluripotent stem cells. Residual undifferentiated stem cells in preparations of stem cell derivatives, including cardiomyocyte differentiation cultures, have potential to proliferate and form teratoma upon transplantation, posing a major hurdle for safe cell therapy. Careful assessment of differentiation cultures and development of strategies to remove undifferentiated stem cells will facilitate qualification of final stem cell products for therapeutic use. In this study, we propose to develop sensitive, nanotechnology-based assays to detect residual undifferentiated cells, characterize cardiomyocyte differentiation cultures at various stages for their propensities to form teratomas, and evaluate strategies to selectively remove residual undifferentiated cells. Technology established in this study will be valuable for the development of novel cell therapy using human pluripotent stem cells.
4 schema:endDate 2016-04-30T00:00:00Z
5 schema:funder https://www.grid.ac/institutes/grid.279885.9
6 schema:identifier N9c343c52aead43d3995788a4a6a030f8
7 Nacb572a87dee41d4989026e1c196b09f
8 schema:inLanguage en
9 schema:keywords applicants
10 assay
11 cardiomyocyte differentiation cultures
12 careful assessment
13 cell therapy
14 description
15 development
16 differentiation culture
17 final stem cell products
18 human pluripotent stem cells
19 major concern
20 major hurdle
21 nanotechnology
22 novel cell therapies
23 pluripotent stem cell therapies
24 pluripotent stem cells
25 potential
26 preparation
27 propensity
28 qualification
29 regenerative medicine
30 residual undifferentiated cells
31 safe cell therapy
32 safety assessment
33 stem cell derivatives
34 strategies
35 study
36 technology
37 teratoma
38 therapeutic use
39 transplantation
40 tumor formation
41 undifferentiated stem cells
42 unlimited cell source
43 various stages
44 schema:name Safety Assessment of Pluripotent Stem Cell Therapy Using Nanotechnology
45 schema:recipient Nf94f8e10d2a14d128637f7e3254457a9
46 sg:person.01207330163.59
47 https://www.grid.ac/institutes/grid.189967.8
48 schema:sameAs https://app.dimensions.ai/details/grant/grant.3805221
49 schema:sdDatePublished 2019-03-07T12:03
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N2709a6fc4aa54a8d9cbc57e565a4b026
52 schema:startDate 2014-08-15T00:00:00Z
53 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8902262
54 sgo:license sg:explorer/license/
55 sgo:sdDataset grants
56 rdf:type schema:MonetaryGrant
57 N2709a6fc4aa54a8d9cbc57e565a4b026 schema:name Springer Nature - SN SciGraph project
58 rdf:type schema:Organization
59 N2ae753aae5064c6fad29b0bde0e7d8c7 schema:currency USD
60 schema:value 426075
61 rdf:type schema:MonetaryAmount
62 N9c343c52aead43d3995788a4a6a030f8 schema:name nih_id
63 schema:value R21HL123928
64 rdf:type schema:PropertyValue
65 Nacb572a87dee41d4989026e1c196b09f schema:name dimensions_id
66 schema:value 3805221
67 rdf:type schema:PropertyValue
68 Nf94f8e10d2a14d128637f7e3254457a9 schema:member sg:person.01207330163.59
69 schema:roleName PI
70 rdf:type schema:Role
71 anzsrc-for:2210 schema:inDefinedTermSet anzsrc-for:
72 rdf:type schema:DefinedTerm
73 sg:person.01207330163.59 schema:affiliation https://www.grid.ac/institutes/grid.189967.8
74 schema:familyName XU
75 schema:givenName CHUNHUI
76 rdf:type schema:Person
77 https://www.grid.ac/institutes/grid.189967.8 schema:name EMORY UNIVERSITY
78 rdf:type schema:Organization
79 https://www.grid.ac/institutes/grid.279885.9 schema:Organization
 




Preview window. Press ESC to close (or click here)


...